Receive the latest alerts via email

New stock valuation – Alexion Pharmaceuticals Inc(ALXN)

Alexion Pharmaceuticals Inc (NASDAQ:ALXN) over-valued by 11%

Website https://alexion.com/
Sector Healthcare
Industry Biotechnology
Fiscal Year End Dec 31, 2020
Market Cap $37,614,854,144
Beta 1.27027
Average Volume $2,428,403
Last Dividend 0%
Price on Feb 8, 2021 $170.27
Autochartist™ Valuation $152.38
Conclusion
11%
over-valued
Download Report
Total
0
Shares
Previous Post

New stock valuation – Aon PLC(AON)

Next Post

New stock valuation – Eastman Chemical Co(EMN)

ARTÍCULOS RELACIONADOS